Vertex Pharmaceuticals, Inc. (VRTX)
469.27
-1.04
(-0.22%)
USD |
NASDAQ |
Feb 19, 16:00
466.48
-2.79
(-0.59%)
Pre-Market: 09:14
Vertex Pharmaceuticals Market Cap : 119.21B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 19.42B |
| Gilead Sciences, Inc. | 187.49B |
| Merck & Co., Inc. | 302.46B |
| Eli Lilly & Co. | 965.26B |
| Pfizer Inc. | 152.72B |
Market Cap Related Metrics
| PE Ratio | 30.60 |
| PS Ratio | 10.03 |
| Price to Book Value | 6.387 |
| Price to Free Cash Flow | 37.91 |
| Price | 469.27 |
| Earnings Yield | 3.27% |
| Operating PE Ratio | 25.54 |
| Normalized PE Ratio | 27.98 |